Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma.

D. Elsasser, H. Stadick, S. Stark, J.G.J. van de Winkel, M. Gramatzki, K.M. Schrott, T. Valerius, W. Schafhauser

Research output: Contribution to journal › Article › Academic › peer-review

Cite this

@article{4907440a450d4789bfe466f479ce04cb,

title = "Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma.",

author = "D. Elsasser and H. Stadick and S. Stark and {van de Winkel}, J.G.J. and M. Gramatzki and K.M. Schrott and T. Valerius and W. Schafhauser",

year = "1999",

language = "Undefined/Unknown",

volume = "19",

pages = "1525--1528",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "2C",

}

TY - JOUR

T1 - Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma.

AU - Elsasser, D.

AU - Stadick, H.

AU - Stark, S.

AU - van de Winkel, J.G.J.

AU - Gramatzki, M.

AU - Schrott, K.M.

AU - Valerius, T.

AU - Schafhauser, W.

PY - 1999

Y1 - 1999

M3 - Article

SN - 0250-7005

VL - 19

SP - 1525

EP - 1528

JO - Anticancer Research

JF - Anticancer Research

IS - 2C

ER -